Welcome to the 4th Allogeneic Cell Therapies Summit
The Allogeneic Cell Therapies Summit is the leading industry-focused meeting that brings together biopharma companies looking to advance the development of safe, effective and commercially viable allogeneic cell therapies.
Whilst allogeneic cell therapies offer a variety of solutions to the shortcomings hampering the clinical and commercial success of autologous therapies, their development are still in the early stages and challenges lie ahead. The leading drug developers in the field have mentioned they require meaningful partnerships to aid with research development, manufacturing, cryopreservation and logistics.
Partnering with the Allogeneic Cell Therapies Summit will establish you as a leading partner in this industry, ensure you capitalize on market share early and show your support in the growth of off-the-shelf therapies.
Why Sponsor with the Allogeneic Cell Therapies Summit?
- Position Yourself as an Industry Thought Leader Now is your chance to get in front of your target key decision makers in the market and demonstrate your expertise through podium presentations, moderating panel discussions or interactive roundtables.
- Raise Brand Awareness: Increase your reach and exposure to new clients, customers and businesses through unique branding opportunities pre and post conference.
- Meet and Network with Industry Pioneers: With a room full of drug developers looking to see how they can effectively commercialize allogeneic cell therapies, fill your pipeline with new leads for 2022 and beyond through one-to-one meetings and networking opportunities.
- Benefit from Market Intelligence: Discover what solutions and services biopharma companies will be investing in to produce allogeneic cell therapies on large scales in 2022 to enable you to match your solutions accordingly.
Email firstname.lastname@example.org to learn how we can help you achieve your business goals faster, more effectively, and more cost-efficiently for 2022 and beyond.